Guangdong Rongtai Pharmaceutical - About the company
Guangdong Rongtai Pharmaceutical is a series A company based in Guangzhou (China), founded in 2004 by Haifeng Zhao. It operates as a Provider of marketing services for pharma industry. Guangdong Rongtai Pharmaceutical has raised $46.3M in funding from Shenzhen Capital Group and Tianjin Haida Venture Capital Management. The company has 445 active competitors, including 11 funded and 46 that have exited. Its top competitors include companies like OPEN Health, Abacus Medicine and Secura Bio.
Company Details
- Website
- khpharm.com
- Email ID
- *****@qq.com
- Phone Number
- +86 **********
Key Metrics
Founded Year
2004
Location
Guangzhou, China
Stage
Series A
Total Funding
$46.3M in 1 round
Latest Funding Round
Investors
Ranked
51st among 445 active competitors
Similar Companies
Sign up to download Guangdong Rongtai Pharmaceutical's company profile
Guangdong Rongtai Pharmaceutical's funding and investors
Guangdong Rongtai Pharmaceutical has raised a total funding of $46.3M over 1 round. Its latest funding round was a Series A round on Jul 21, 2021 for $*****. 3 investors participated in its latest round. Guangdong Rongtai Pharmaceutical has 3 institutional investors.
Here is the list of recent funding rounds of Guangdong Rongtai Pharmaceutical:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 21, 2021 | 7165187 | Series A | 2601957 | 3284367 | 4851525 | 8446988 |
Access funding benchmarks and valuations. Sign up today!View details of Guangdong Rongtai Pharmaceutical's funding rounds and investors
Guangdong Rongtai Pharmaceutical's founders and board of directors
Founder? Claim ProfileThe founders of Guangdong Rongtai Pharmaceutical is Haifeng Zhao.
Here are the details of Guangdong Rongtai Pharmaceutical's key team members:
- Haifeng Zhao: Owner of Guangdong Rongtai Pharmaceutical.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Guangdong Rongtai Pharmaceutical's Competitors and alternates
Top competitors of Guangdong Rongtai Pharmaceutical include OPEN Health, Abacus Medicine and Secura Bio. Here is the list of Top 10 competitors of Guangdong Rongtai Pharmaceutical, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  OPEN Health 2016, Marlow (United Kingdom), Acquired | Provider of healthcare marketing services | $5.28M | 62/100 | |
2nd | _1540298187624.png?devicePixelRatio=2&height=30&width=30){kind=logo} Abacus Medicine 2004, Copenhagen (Denmark), Series A | Consulting services for market access, health economics and outcomes research | $57.6M | 56/100 | |
3rd |  Secura Bio 2018, Henderson (United States), Series A | Provider of consulting services for market access and health outcomes | $55M | 48/100 | |
4th |  Bridge Medical 2011, Chatham (United Kingdom), Acquired | Provider of evidence and outcomes research for biopharmaceutical companies | - | - | 46/100 |
5th | PHMR 2007, London (United Kingdom), Acquired | Provider of market access services | - | - | 44/100 |
6th | Provider of drinking water testing, environmental analysis, and marketing services to the pharmaceutical industry | - | 44/100 | ||
7th |  Target RWE 2017, Durham (United States), Acquired | Provider of marketing services to the pharmaceutical industry | - | 43/100 | |
8th | BioPharm Communications 2005, New Hope (United States), Acquired | Provider of marketing services to pharmaceutical and biopharma companies | - | 43/100 | |
9th | Taevas Global 2019, Hyderabad (India), Unfunded | Provider of market entry and regulatory compliance services for life sciences companies | - | - | 41/100 |
10th |  bpcruk 2016, United Kingdom, Public | Provider of marketing services to biopharma sector | - | 40/100 | |
51st |  Guangdong Rongtai Pharmaceutical 2004, Guangzhou (China), Series A | Provider of marketing services for pharma industry | $46.3M | 28/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Guangdong Rongtai Pharmaceutical's competitors? Click here to see the top ones
Guangdong Rongtai Pharmaceutical's Investments and acquisitions
Guangdong Rongtai Pharmaceutical has made no investments or acquisitions yet.
Reports related to Guangdong Rongtai Pharmaceutical
Here is the latest report on Guangdong Rongtai Pharmaceutical's sector:
News related to Guangdong Rongtai Pharmaceutical
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Guangdong Rongtai Pharmaceutical
Explore our recently published companies
- IndyKite - San Francisco based, 2021 founded, Seed company
- Enhance.ai - 2017 founded, Unfunded company
- ShreeAI - Indore based, 2026 founded, Unfunded company
- Stuv AI - Nagpur based, 2025 founded, Unfunded company
- RSR Content Creation - Chennai based, 2016 founded, Funding Raised company
- Radmat - Funding Raised company
